Hikma Pharmaceuticals PLC Accounts Payable for the year ending December 31, 2024: USD 358.00 M

Hikma Pharmaceuticals PLC Accounts Payable is USD 358.00 M for the year ending December 31, 2024, a 15.86% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
  • Hikma Pharmaceuticals PLC Accounts Payable for the year ending December 31, 2023 was USD 309.00 M, a 6.19% change year over year.
  • Hikma Pharmaceuticals PLC Accounts Payable for the year ending December 31, 2022 was USD 291.00 M, a 11.07% change year over year.
  • Hikma Pharmaceuticals PLC Accounts Payable for the year ending December 31, 2021 was USD 262.00 M, a -6.09% change year over year.
  • Hikma Pharmaceuticals PLC Accounts Payable for the year ending December 31, 2020 was USD 279.00 M, a -2.45% change year over year.
Key Data
Date Accounts Payable Short-Term Debt Long-Term Debt Total Liabilities